Navigation Links
Accera, Inc. to Present Results of Phase II Study in Alzheimer's,Disease at American Academy of Neurology Meeting

riedrich's ataxia, and canine cognitive dysfunction.

About Accera, Inc.

Based in Broomfield, CO, Accera, Inc. is a privately held biopharmaceutical company focused on developing novel drugs for neurodegenerative diseases. The company's lead candidate, AC-1202, is a first- in-class molecule currently in Phase II clinical trials for Alzheimer's disease and age-associated memory impairment. A key element of Accera's strategy is to develop AC-1202 and other small molecule compounds in its pipeline with corporate partners for a range of memory and cognition disorders associated with neurological conditions and aging. www.accerapharma.com

    For information contact:

    Meghan Feeks

    Richard Lewis Communications, Inc.

    212-827-0020
mfeeks@rlcinc.com

CONTACT: Meghan Feeks of Richard Lewis Communications, Inc.,+1-212-827-0020, or , for Accera, Inc. mfeeks@rlcinc.com

Web site: http://www.accerapharma.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2

Related medicine technology :

1. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
2. Accera, Inc. Announces Results of Phase II Study in Alzheimers Disease at American Academy of Neurology Meeting
3. The Past, Present and Future of HLA Typing
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference

Post Your Comments:
(Date:11/6/2009)...Nov. 6 Caraco Pharmaceut...nched ketorolac tromethamine ophthalmic solution, ...nd Drug Administration (FDA) for Sun Pharma,s Abbr...ular® opthalmic solution on the first day fol...ac is therapeutically equivalent to Acular® O...
(Date:11/5/2009)..., N.J., Nov. 5 Osteotech...field of biologic products for regenerative healin...quarter ended September 30, 2009. ,, "During th...ase of our three new biologic products MagniFuse(...d Plexur M® Innovative Grafting," said Sam Ow...
(Date:11/5/2009)...ntario, Nov. 5 Helix Bio...unced today that its Phase II trial of Topical Int...warts (AGW) has completed patient enrollment, with...e trial. ,, The double-blind and placebo-contro...s in Germany and Sweden. Patients participating i...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 1Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 2Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 3Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery 4564 1Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery 4564 2Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery 4564 3Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery 4564 4Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery 4564 5Defeating nicotines double role in lung cancer 48187 1Defeating nicotines double role in lung cancer 48187 2Defeating nicotines double role in lung cancer 48187 3
...Overweight and Obese Type 2 Diabetics to Assess Sa...lized Secondary Endpoints, PLYMOUTH MEETING, Pa.,...ay announced that dosing of subjects has,begun in ...se 1 study of,trodusquemine (MSI-1436), in overwei...l therapeutic for the treatment of type 2 diabetes...
...K, Calif., Jan. 16 Cogentus Pharmaceuticals,Inc. ...l study to confirm,the full antiplatelet activity ...68 is a once-daily capsule that combines clopidogr... and Sanofi-Aventis as Plavix(R)) with,a gastropro...al safety of,antiplatelet therapy., (Logo: http:...
Other Medicine Technology:Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436) 2Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436) 3Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436) 4Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168 2
(Date:11/7/2009)...PRNewswire-USNewswire/ -- Speaker Nancy Pelosi sp...62, the Affordable Health Care for America Act. T...t. Below are the Speaker,s remarks. ,, "Madam...ment for our nation and for American families. Fo...itical philosophy -- as far back as Teddy Roosevel...
(Date:11/7/2009)...wire/ -- Calling this a "defining moment" for the ...ent J. James Rohack, M.D., today addressed medical... medical specialty societies at the opening of the...alth system reform will top the agenda. ,, (Log...AMALOGO ) ,, "Over the next 72 hours, this AM...
(Date:11/7/2009)...ewswire-USNewswire/ -- The U.S. bishops November 7...vote for the Stupak-Ellsworth Amendment to the hea...-Kaptur-Dahlkemper-Lipinski-Smith Amendment will k...ng and conscience protections in the Affordable He... ,, The letter was signed by Cardinal Justin Ri...
(Date:11/7/2009)...all youth will rebel, expert says , , SATU...kely to behave badly if their parents expect them ...ieve they are simply being realistic might actuall...ty Buchanan, a psychology professor at Wake Forest...university news release. "Negative expectations on...
(Date:11/7/2009)...et ‘sweatox’ or ‘Boytox’, ...he anti-ageing jab ‘Breastox’ – ...acute;colletage, can reduce the appearance of wrin...e breasts, leaving smoother, younger-looking skin....09 -- Transform, the UK’s largest group of ...
Breaking Medicine News(10 mins):Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:UK Boobs Get a Boost with 'Breastox' 2
...ling should be mercilessly shot down, according to...roup activists. The group’s mandate is to communic...mendation that purports to introduce assisted // s...groups based on faith, and health groups have join...
...expressed their disappointment over the inadequate...transfusions of blood infected with hepatitis C //...tion became available only in 1991, which led many...g demands from campaigners to look into the happen...
... girl died after eating a single sweet as she suff...as a strawberry cream cake but had // failed to id... suddenly developed difficulty in breathing and lo...damage. Five days later, her mother Sandra ...
...and chemistry between new partners wanes anywhere ... by a desire for companionship, according to novel...aly have now been able to place a finger on probab...hormones, responsible for the body Chemistry that ...
...an insight into the 'déjà vu' phenomenon, a sensat...ings before. // Leeds university researchers have ... memory process. Though all of us have experienced...University, saying that he had already witnessed h...
... human beings only as recently as between 13,000 a...The earlier theories contend that the bond // last...d by Darcy Morey, and takes canine burials into co...did not become common between 15,000 and 14,000 ye...
Other Medicine News:Health News:Sex Spell Lasts Two Years Graduating To 'Cuddles' Companionship 2Health News:Mystery Behind The Déjà Vu Phenomenon Yet To Be Resolv 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: